ADVANCE: A multisite trial of bioabsorbable steroid‐eluting sinus implants
- 21 October 2011
- journal article
- clinical trial
- Published by Wiley in The Laryngoscope
- Vol. 121 (11) , 2473-2480
Abstract
Objectives/Hypothesis: Disease recurrence and adverse wound healing in the form of inflammation, polyposis, adhesions, and middle turbinate lateralization may induce suboptimal outcomes following sinus surgery. The study objective was to assess the safety and effectiveness of a bioabsorbable, steroid‐eluting implant used following functional endoscopic sinus surgery in patients with chronic rhinosinusitis (CRS).Study Design: Prospective, multicenter, single‐cohort trial enrolling 50 patients.Methods: The study allowed bilateral or unilateral steroid‐eluting implant placement. Oral and topical steroids were withheld for 60 days postoperatively. Endoscopic follow‐up was performed to 60 days. Patient‐reported outcomes (Sino‐Nasal Outcome Test‐22 Questionnaire, Rhinosinusitis Disability Index) were collected to 6 months. Efficacy was assessed by grading inflammation, polyp formation, adhesions, and middle turbinate position. Safety assessment included ocular exams at baseline and 30 days.Results: Implants were successfully placed in all 90 sinuses. Mean inflammation scores were minimal at all time points. At 1 month, the prevalence of polypoid edema was 10.0%, significant adhesions 1.1%, and middle turbinate lateralization 4.4%. Changes from baseline in patient‐reported outcomes were statistically significant (P < .0001). No clinically significant changes from baseline in intraocular pressure occurred.Conclusions: This consecutive case series provides clinical evidence of the safety, effectiveness, and clinical utility of a bioabsorbable steroid‐eluting implant for use in CRS patients. The implant was associated with favorable rates of sinus patency. At 1 month, minimal degrees of inflammation and adhesions were observed, suggesting a positive clinical impact of local steroid delivery without evidence of ocular risk. Laryngoscope, 121:2473‐2480, 2011Keywords
This publication has 39 references indexed in Scilit:
- Safety and efficacy of a novel bioabsorbable, steroid‐eluting sinus stentInternational Forum of Allergy & Rhinology, 2011
- Quality‐of‐life outcomes after endoscopic sinus surgery: How long is long enough?Otolaryngology–Head and Neck Surgery, 2010
- Triamcinolone‐impregnated nasal dressing following endoscopic sinus surgery: A randomized, double‐blind, placebo‐controlled studyThe Laryngoscope, 2010
- Operative findings in the frontal recess at time of revision surgeryAmerican Journal of Otolaryngology, 2010
- A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitisOtolaryngology–Head and Neck Surgery, 2008
- Steroids in OtolaryngologyThe Laryngoscope, 2008
- Mometasone Furoate Nasal SprayDrug Safety, 2007
- Rhinosinusitis: Developing guidance for clinical trialsJournal of Allergy and Clinical Immunology, 2006
- Efficacy and safety of mometasone furoate nasal spray in nasal polyposisJournal of Allergy and Clinical Immunology, 2005
- Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal sprayJournal of Allergy and Clinical Immunology, 2000